Theravance — IVAO

Rick E Winningham
Chairman and Chief Executive Officer
Michael W. Aguiar
Senior Vice President and Chief Financial Officer
Leonard M. Blum
Senior Vice President and Chief Commercial Officer
David L. Brinkley
Head, Business Development
Mathai Mammen, M.D., Ph.D.
Senior Vice President, Research and Early Clinical Development
Bradford J. Shafer
Senior Vice President, General Counsel and Secretary
Steve Barriere, Pharm.D.
Vice President, Clinical and Medical Affairs
Daniel M. Canafax, Pharm.D.
Vice President, Clinical Development
Rebecca Coleman, Pharm.D.
Vice President, Regulatory Affairs and Quality
Michael Conner, D.V.M.
Vice President, Safety Assessment/Toxicology
Oranee T. Daniels, M.D.
Vice President, Clinical Pharmacology and Experimental Medicine
Dennis O. Driver
Vice President, Human Resources
Jeffrey T. Finer M.D., Ph.D.
Vice President, Molecular and Cellular Biology
Renee D. Gala
Vice President, Finance
Jeffrey A. Hagenah, Ph.D.
Vice President & Chief Patent Counsel
Sharath S. Hegde, Ph.D.
Vice President, Pharmacology
Alan Hopkins Ph.D.
Vice President of Biometrics
Junning Lee, Ph.D.
Vice President, Technical Operations
Dan Marquess, D.Phil.
Vice President, Medicinal Chemistry
Edmund J. Moran, Ph.D.
Vice President, R&D Program Leader
Carlos A. Parra
Vice President, Quality
Kenneth R. Pitzer, D.V.M.
Vice President, Strategic and Commercial Planning
Heather Shane
Vice President and Assistant General Counsel
Philip Worboys, Ph.D.
Vice President, Drug Metabolism and Pharmacokinetics